Medline Inc. Class A (MDLN)
MDLN · Health Care · 
United States
Medline Inc. Class A (MDLN) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.18%. Anyone who holds an ETF containing Medline also has an indirect stake in the company.
Data and Charts: Medline
Key Data for Medline
Medline Stock Price Chart
The Medline chart shows daily closing prices and is set to the current year by default. The stock is down 23.5% year to date. The last recorded close on October 30, 2026, was $32.12, at 3% of the 52-week range.
Price series from our database since Dec 17, 2025, 219 daily values.
Medline Stock Performance
| Year to date | -23.5% | 1 year | – |
|---|---|---|---|
| 1 month | -7.4% | 3 months | -18.2% |
Measured in euros, Medline is down 19.6% year to date. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Medline
What ETF Is Medline In?
Medline has above-average ETF coverage and is held by 16 of the 104 ETFs we track, which together follow 7 indices. That puts the stock in more ETFs than 76.8% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 0.18% | €1.77 |
| XDWH | MSCI World Health Care | 0.13% | €1.31 |
| SPFS | MSCI World Health Care | 0.13% | €1.29 |
| SWWD | MSCI World | 0.02% | €0.20 |
| SPPW | MSCI World | 0.02% | €0.20 |
| XD9U / XD9D | MSCI USA | 0.02% | €0.18 |
| XDWD / XDWL | MSCI World | 0.01% | €0.13 |
| WIMI | MSCI World IMI | 0.01% | €0.13 |
| SPYY | MSCI ACWI | 0.01% | €0.11 |
| EUNL | MSCI World | 0.01% | €0.10 |
| IUSQ | MSCI ACWI | 0.01% | €0.10 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Medline, based on each fund's latest holdings list.
US-listed ETFs holding Medline (weight per latest SEC filing): ONEQ 0.06%, VTI 0.02%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Medline overlaps with the rest of a portfolio.
Which Tracked Investors Hold Medline?
Medline is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. Of the 4 tracked managers holding the stock, 3 added and 1 cut.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Lone Pine Capital | 20,968,367 | $827M | increased by 9,179,211 |
| Viking Global Investors | 4,841,080 | $191M | reduced by 6,592,912 |
| Soros Fund Management | 1,638,244 | $65M | increased by 351,810 |
| Bridgewater Associates | 19,847 | $782,766 | newly added |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
What Medline Executives and Directors Traded Recently
| Date | Person | Type | Shares | Price |
|---|---|---|---|---|
| Oct 8, 2026 | GIC Private Ltd 10% owner | Sell | 7,816,987 | $35.15 |
| Oct 6, 2026 | GIC Private Ltd 10% owner | Sell | 7,183,013 | $35.05 |
| Oct 6, 2026 | GIC Private Ltd 10% owner | Sell | 2,088,987 | $35.05 |
| Oct 5, 2026 | GIC Private Ltd 10% owner | Sell | 1,688,690 | $35.78 |
| Oct 2, 2026 | GIC Private Ltd 10% owner | Sell | 7,146,941 | $34.33 |
| Oct 2, 2026 | GIC Private Ltd 10% owner | Sell | 2,570,999 | $35.35 |
The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded.
“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32.
Stocks With ETF Exposure Similar to Medline
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Medline | – | – | – | 43.8% | 4.1% | +11.5% |
 Insmed Incorporated | 16 | – | -42.0% | 54.9% | -210.5% | +66.7% |
 Natera | 16 | – | +114.4% | 46.7% | -9.0% | +35.9% |
| Neurocrine Biosciences | 16 | – | +5.8% | 36.2% | 16.7% | +21.4% |
 Roivant Sciences | 16 | – | +88.5% | 39.4% | -3,629.2% | -71.6% |
 Revolution Medicines | 16 | – | +225.0% | 56.2% | – | – |
 United Therapeutics Corporation | 16 | – | +32.0% | 41.2% | 41.9% | +10.6% |
 Royalty Pharma Plc | 16 | – | +81.9% | 23.4% | 32.4% | +5.1% |
 Boston Scientific Corporation | 16 | – | -58.3% | 30.9% | 14.4% | +19.9% |
These stocks reach a portfolio through largely the same funds as Medline. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Medline
Medline Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 23.2 | 0.2 | 1.0% |
| FY ended Dec 2024 | 25.5 | 1.2 | 4.6% |
| FY ended Dec 2025 | 28.4 | 1.2 | 4.1% |
Technical Analysis: Medline
Medline Risk Metrics
The close on Oct 30, 2026, was 35.7% below the highest close since Dec 17, 2025. That high was reached on Feb 24, 2026. When the S&P 500 rose or fell 1%, Medline moved 0.57% on average in the same direction (past 218 trading days). The correlation of 0.17, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Medline.
What Medline Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| Insulet Corporation | +0.50 | |
| Baxter International Inc. | +0.48 | |
| DaVita Inc. | +0.48 | |
| Thomson Reuters Corporation | +0.47 | |
| Align Technology Inc. | +0.46 | |
| Henry Schein Inc. | +0.46 | |
| Brent crude oil | -0.40 | |
| WTI crude oil | -0.38 | |
| Targa Resources Corp. | -0.38 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
